Veeva Systems has acquired Physicians World, a leading provider of speakers bureau services.
W2O Acquires ISO.health to Broaden International Reach of its Scientific & Medical Marketing Communications Solutions
W2O announced the acquisition of ISO.health, continuing the company’s global expansion in scientific and medical marketing communications.
Takeda Pharmaceutical Co. Ltd. will sell some over-the-counter and prescription drugs to Germany’s Stada Arzneimittel AG for a total value of $660 million.
EVERSANA, a leading independent provider of commercial services to the life science industry, announced an agreement to acquire Canada-based Cornerstone Research Group Inc.
Alexion Pharmaceuticals Inc. agreed to buy smaller biotech company Achillion Pharmaceuticals Inc. in a deal initially valued at $930 million.
UCB will acquire U.S.-based Ra Pharmaceuticals in a $2.1 billion deal that will enable the Belgian drugmaker to offer new treatment options for several rare diseases in neurology and immunology.
W2O – a leading independent provider of analytics-driven, digital-first marketing communications to the healthcare sector – acquired Arcus Medica, a recognized leader in medical and scientific communications.
Shares of Dova Pharmaceuticals were up more than 38 percent after Sweden-based Sobi announced the intended acquisition of the North Carolina-based company for $915 million.
Clovis Oncology Inc. entered into a global licensing and collaboration agreement with 3B Pharmaceuticals GmbH, a private German biotechnology company developing targeted radiopharmaceutical drugs and diagnostics for oncology indications with a high unmet medical need.
Denmark’s Lundbeck agreed to buy Alder BioPharmaceuticals in a deal valued at almost $2 billion, hoping to reap profits from a potential blockbuster migraine drug.